Asia’s largest drugmaker, Takeda Pharmaceuticals, may face nearly 10,000 lawsuits in the U.S. over claims that the type 2 diabetes drug, Actos, caused them to develop bladder cancer.
In June of 2011, U.S. drug regulators found that those who take Actos for over a year have an increased risk of developing bladder cancer. A group of judges is now currently deciding whether or not the suits should be gathered together for their pre-trial proceedings.This medication was nearly 27 percent of the company’s revenue last year.
If you or a loved one has been developed bladder cancer as a result of using Actos for over a year, you need experienced representation on your side at this time. Contact the Actos lawsuit lawyers of Williams Kherkher by calling 800-641-9810 today.